What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Cancer
Mark J. Smyth mainly investigates Immunology, Immune system, Cancer research, Immunotherapy and Cancer.
His Interleukin 12 research extends to Immunology, which is thematically connected.
His Interleukin 12 study combines topics from a wide range of disciplines, such as Perforin, Natural killer cell, Antigen-presenting cell and Cell biology.
His Cancer research research incorporates themes from Tumor necrosis factor alpha, CD8, Interferon gamma, Adoptive cell transfer and Disease.
His work deals with themes such as Melanoma, Cytokine and Oncology, which intersect with Immunotherapy.
His Cancer study combines topics in areas such as Cell type, Immunity and Mechanism of action.
His most cited work include:
- Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion (3431 citations)
- Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion (3431 citations)
- Natural Innate and Adaptive Immunity to Cancer (1288 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Immunology, Cancer research, Immune system, Cytotoxic T cell and Immunotherapy.
His work on Cancer expands to the thematically related Immunology.
His study in Cancer research is interdisciplinary in nature, drawing from both Immune checkpoint, T cell, Adoptive cell transfer and Receptor.
His studies in Cytotoxic T cell integrate themes in fields like Molecular biology and T lymphocyte.
He combines subjects such as Cytokine and Oncology with his study of Immunotherapy.
His work carried out in the field of Interleukin 21 brings together such families of science as Antigen-presenting cell, IL-2 receptor and Cell biology.
He most often published in these fields:
- Immunology (75.43%)
- Cancer research (44.04%)
- Immune system (43.40%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (44.04%)
- Immune system (43.40%)
- Immunotherapy (33.09%)
In recent papers he was focusing on the following fields of study:
Mark J. Smyth spends much of his time researching Cancer research, Immune system, Immunotherapy, Cancer and Immunology.
His Cancer research research is multidisciplinary, incorporating elements of Immune checkpoint, Cytotoxic T cell, CD8 and Cancer immunotherapy.
His Immune system study incorporates themes from Tumor necrosis factor alpha and Antigen.
The Immunotherapy study combines topics in areas such as T cell, Adjuvant, Oncology and Melanoma.
His studies examine the connections between Cancer and genetics, as well as such issues in Adenosine, with regards to Adenosine receptor.
His Immunology study integrates concerns from other disciplines, such as Metastasis and Disease.
Between 2016 and 2021, his most popular works were:
- Cancer immunoediting and resistance to T cell-based immunotherapy. (287 citations)
- Cancer immunoediting and resistance to T cell-based immunotherapy. (287 citations)
- Targeting immunosuppressive adenosine in cancer (258 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Immune system
His primary areas of study are Cancer research, Immune system, Immunology, Immunotherapy and Cancer.
His research integrates issues of Immune checkpoint, T cell, Cytotoxic T cell, TIGIT and Cancer immunotherapy in his study of Cancer research.
His biological study spans a wide range of topics, including Natural killer cell and Receptor.
As part of one scientific family, Mark J. Smyth deals mainly with the area of Immunology, narrowing it down to issues related to the Oncology, and often Phases of clinical research and Pembrolizumab.
The concepts of his Immunotherapy study are interwoven with issues in Cytokine, Immunosuppression, Downregulation and upregulation, Melanoma and Drug resistance.
His Cancer research includes elements of Adenosine and Adenosine receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
